Seqster builds a multi-dimensional healthcare data platform that gives patients and enterprises real-time access to secure, longitudinal, and comprehensive health data. Its proprietary technology aggregates electronic health records, pharmacy, lab, genomic (DNA), fitness wearable, and social determinants of health data at the patient level and at scale. The company was founded in 2016 by Ardy Arianpour, Dr. Xiang Li, and Dana Hosseini to address fragmented data silos across healthcare. Leading biopharmaceutical companies have used Seqster for remote clinical trials and automated data collection, a capability the company says is especially critical during the COVID-19 pandemic. Seqster recently raised $12M in a Series A to grow and evolve its technology to meet demand. Management and investors expect the capital to enable further expansion into healthcare and broader deployment of its platform.

Total raised

$12M

Funding rounds

1

Latest round

Series A

Latest activity

May 2021